Ambiguous pricing of topical dermatological products: A survey of brands from two South Asian countries

Authors

  • P. Ravi Shankar
  • P. Subish
  • Ram Bahadur Bhandari
  • Pranaya Mishra
  • Archana C Saha

Keywords:

Dermatological preparations, drugs, drug information, price variation

Abstract

Background Cost of drugs is an important factor influencing compliance with treatment. Skin diseases are a common problem inNepal. A large number of dermatological preparations are available. Studies on the price variation between brands are lacking. Hence the present study was carried out to obtain information on the price variation between different brands of topical dermatological preparations. The variation within and between Nepalese and Indian brands was also studied. Materials and methods The prices of brands were obtained from three sources, the pharmacy price list of the Manipal hospital, the Nepal Drug review and Advance Drug Review. The percentage cost variation was calculated using the formulaPercentage cost variation = Cost of highest priced – cost of lowest priced brand x 100                                                         Cost of lowest priced brandThe drugs were grouped into therapeutic categories and the average variation for different categories was calculated. Results A total of 37 Nepalese and 397 Indian brands were surveyed; 40 drugs or drug combinations were studied. Twenty-five drugs (62.5%) showed more than 75% variation. The combination of betamethasone, gentamicin and clotrimazole showed the maximum variation. The Nepalese brands were generally cheaper than their Indian counterparts but there were exceptions. Among the therapeutic categories, the maximum variation was observed among topical antiseptics, topical antivirals and corticosteroids. The variation within Nepalese brands was less compared to that within Indian ones. Conclusions There was substantial price variation observed. Information on product quality and prices should be widely disseminated. ‘True’ competition between brands should be encouraged. 

References

Humagain B, Bista B, Maharjan N et al. variation of prices in medicine: a market survey. Bull Nepal Pharm Assoc 2003; 14: 7-10.

World Health Organization. Introduction to drug utilization research. Oslo: 2003.

Shankar PR. Compliance and rational use of drugs. Drug Inform Bull 2004; 2: 1-2.

Monaghan MJ, Monaghan MS. Do market components account for higher US prescription prices? Ann Pharmacother 1996; 30: 1489-94.

Roy V, Rewari S. Ambiguous drug pricing: a physician’s dilemma. Indian J Pharmacol 1998; 30: 404-7.

Kolassa M. Guidance for clinicians in discussing and comparing the price of pharmaceutical agents. J Pain Symptom Manage 1994; 9: 235-43.

Department of Health Services. Annual report 2060/61 (2003/2004 AD). Kathmandu: 2005

Sarkar PK. A rational drug policy. Indian J Med Ethics 2004; 12: **.

Berki SE, Richards JW, Weeks HA. The mysteries of prescription pricing in retail pharmacies. Med Care 1977; 15: 241-50.

Health Action International Europe, World Health Organization. Medicine prices- a new approach to measurement. http://www.haiweb.org/medicinesprices. Accessed on March 28, 2006.

Wachter DA, Joshi MP, Rimal B. Antibiotic dispensing by drug retailers in Kathmandu, Nepal. Trop Med Int Health 1999; 4: 782-8.

Greenhalgh T. Drug prescription and self-medication in India an exploratory study. Soc Sci Med 1987; 25: 307-18.

Shankar PR, Partha P, Shenoy N. Self-medication and non-doctor prescribing practices in Pokhara valley, Western Nepal: a questionnaire-based study. BMC Fam Pract 2002; 3: 17.

Rataboli PV, Garg A. Confusing brand names: Nightmare of medical profession. J Postgrad Med 2005; 51: 13-6.

Frazier LM, Brown JJ, Divine GW et al. Can physician education lower the cost of prescription drugs? A prospective. Controlled trial. Ann Intern Med 1991; 115: 116-21.

Wertheimer AI, Grumer SK. Overview of international pharmacy pricing. Pharmacoeco 1992; 2: 449-55.

Kucukarslan S, Hakim Z, Sullivan D et al. Points to consider about prescription drug price: an overview of federal policy and pricing studies. Clin Ther 1993; 15: 726-63.

Downloads

Published

2017-01-03

How to Cite

1.
Shankar PR, Subish P, Bhandari RB, Mishra P, Saha AC. Ambiguous pricing of topical dermatological products: A survey of brands from two South Asian countries. J Pak Assoc Dermatol [Internet]. 2017Jan.3 [cited 2026Mar.3];16(3):134-40. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/865

Issue

Section

Original Articles

Most read articles by the same author(s)